Press release
North American Anticoagulants Market to 2026, Future Outlook, COVID-19 Impact Analysis, Forecast 2020-2026
The North American anticoagulants market is estimated to grow at a CAGR of 7.2% during the forecast period. An increasing approval for anticoagulants has been witnessed in the US owing to the rising incidences of heart diseases. The emerging focus on launches of generics has also been reported in the region. For instance, in June 2020, Gland Pharma Ltd. and its collaborators Athenex Pharmaceutical Division and MAIA Pharmaceuticals Inc. declared the US introduction of a ready-to-use Bivalirudin injection. It is an anticoagulant indicated for the treatment of patients who are experiencing percutaneous coronary intervention (PCI). This comprises patients suffering from heparin-induced thrombocytopenia, thrombosis syndrome, and heparin-induced thrombocytopenia.A full report of North American Anticoagulants Market is available at: https://www.omrglobal.com/industry-reports/north-american-anticoagulants-market
Additionally, in December 2019, the US FDA approved two applications for the first generics of Eliquis (apixaban) tablets. These medications are intended to minimize the chances of systemic embolism and stroke in patients who are suffering from nonvalvular atrial fibrillation. The approval of the generic apixaban is granted to Micro Labs Ltd. and Mylan Pharmaceuticals Inc. The approval of these new drugs is supporting to increase the safety and efficacy of anticoagulants, which in turn, will further accelerate the market growth.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-anticoagulants-market
Scope of the North American Anticoagulants Market
Market Coverage
• The market number available for 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Type and Application
• Countries Covered- US and Canada
• Competitive Landscape- Johnson & Johnson Services, Inc., Bristol Myers Squibb Co., Pfizer Inc., Daiichi Sankyo Co. Ltd., and Boehringer Ingelheim GmbH
Recent Strategic Initiatives in the North American Anticoagulants Market
• In October 2020, Janssen declared that it submitted a supplemental New Drug Application (sNDA) to the FDA to increase the XARELTO application for peripheral artery disease (PAD) patients to comprise decreasing the risk of major thrombotic vascular events, including amputation and heart attack, in symptomatic patients after recent lower-extremity revascularization (LER). It is currently approved to decrease the risk of major CVD events in patients with chronic PAD or coronary artery disease (CAD).
• In January 2019, AMAG Pharmaceuticals, Inc. acquired Perosphere Pharmaceuticals Inc., a biopharmaceutical firm. With this acquisition, AMAG will include ciraparantag to its drug development portfolio. It is in development for application in patients treated with low molecular weight heparin (LMWH) or novel oral anticoagulants (NOACs).
Key questions addressed by the report
• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID-19forecast
o Most affected segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/north-american-anticoagulants-market
North American Anticoagulants Market-Segmentation
By Type
• Novel Oral Anticoagulants (NOACs)
• Vitamin K Antagonist
• Heparin and Low Molecular Weight Heparin (LMWH)
By Application
• Pulmonary Embolism
• Atrial Fibrillation/Myocardial Infarction (Heart Attack)
• Deep Vein Thrombosis (DVT)
• Others
North American Anticoagulants Market– Segment
by Country
• US
• Canada
Company Profiles
• Abbott Laboratories
• Baxter International Inc.
• Boehringer Ingelheim GmbH
• Bristol Myers Squibb Co.
• Daiichi Sankyo Company, Ltd.
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Mylan N.V.
• Pfizer Inc.
• Portola Pharmaceuticals, Inc.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North American Anticoagulants Market to 2026, Future Outlook, COVID-19 Impact Analysis, Forecast 2020-2026 here
News-ID: 2238533 • Views: …
More Releases from Orion Market Research

Environment Conservation and Wildlife Organization Market Rising Demand and Grow …
In 2023, the global market for environment, conservation, and wildlife organizations was approximately USD 26.2 billion, and by 2033, it is projected to reach around USD 41.5 billion, reflecting a compound annual growth rate (CAGR) of approximately 5.0% from 2024 to 2033.
Environment Conservation and Wildlife Organization Market Overview
The environment, conservation, and wildlife organizations market is experiencing steady growth, driven by increasing public awareness of environmental issues and the need for…

Wooden Furniture Market Size Analysis, Competitive Insights, Leading Players and …
In 2023, the global wooden furniture market was valued at approximately USD 235.3 billion, and by 2033, it is projected to reach around USD 327.7 billion, reflecting a compound annual growth rate (CAGR) of approximately 3.4% from 2024 to 2033.
Wooden Furniture Market Overview
The global wooden furniture market is experiencing steady growth, driven by increasing consumer demand for sustainable and aesthetically pleasing home furnishings. Factors such as rising disposable incomes, urbanization,…

Warehouse Management Systems Market Size Analysis, Competitive Insights, Leading …
In 2023, the global Warehouse Management Systems (WMS) market was approximately USD 3.2 billion, and by 2033, it is expected to reach around USD 9.4 billion, reflecting a compound annual growth rate (CAGR) of approximately 11.4% from 2024 to 2033.
Warehouse Management Systems Market Overview
The Warehouse Management Systems (WMS) market is rapidly growing as businesses increasingly seek to optimize their supply chain and inventory management processes. WMS solutions help improve operational…

Space Technology Market Rising Demand and Growth Forecast Through 2033
The global space technology market was valued at approximately USD 443.20 billion in 2023, and is projected to grow to about USD 916.85 billion by 2033, representing a compound annual growth rate (CAGR) of roughly 7.54% during the period from 2024 to 2033.
Space Technology Market Overview
The space technology market is experiencing strong expansion, driven by a surge in satellite innovation, advances in launch systems, and a growing wave of commercial…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…